UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 20, 2004
--------------
Escalon Medical Corp.
------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Pennsylvania 0-20127 33-0272839
---------------- ---------------- -------------------
(State or other (Commission file (IRS employer
jurisdiction of number) identification no.)
incorporation)
575 East Swedesford Road, Suite 100
Wayne, Pennsylvania 19087
---------------------------------------- ----------
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: (215) 688-6830
--------------
N/A
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 5. Other Events and Regulation FD Disclosure.
On April 20, 2004, we issued a press release announcing our waiver
of two conditions under our announcement of a proposed exchange offer for all
the outstanding ordinary shares of Drew Scientific Group PLC ("Drew") made on
April 8, 2004. A copy of the press release is attached as an exhibit to, and is
incorporated by reference into, this Form 8-K current report.
Item 7. Financial Statements and Exhibits.
(c) Exhibits.
The following exhibit is filed herewith:
Exhibit No. Description
99.1 Press release issued by Escalon Medical
Corp. dated April 20, 2004
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ESCALON MEDICAL CORP.
Date: April 20, 2004 By: /s/ Richard J. DePiano
-------------------------
Richard J. DePiano
Chairman and
Chief Executive Officer
3
EXHIBIT INDEX
Exhibit
Number Description
------- -----------
99.1 Press release dated April 20, 2004 issued by the Company.